Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    18272891 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: rituximab
2 Recruiting Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Condition: RELAPSING REMITTING MULTIPLE SCLEROSIS
Intervention:

Study has passed its completion date and status has not been verified in more than two years.